Modulation of human mesenchymal stem cell immunogenicity through forced expression of human cytomegalovirus us proteins.
Mesenchymal stem cells (MSC) are promising candidates for cell therapy, as they migrate to areas of injury, differentiate into a broad range of specialized cells, and have immunomodulatory properties. However, MSC are not invisible to the recipient's immune system, and upon in vivo administrati...
Main Authors: | Melisa A Soland, Mariana G Bego, Evan Colletti, Christopher D Porada, Esmail D Zanjani, Stephen St Jeor, Graça Almeida-Porada |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3364258?pdf=render |
Similar Items
-
Mesenchymal stem cells engineered to inhibit complement-mediated damage.
by: Melisa A Soland, et al.
Published: (2013-01-01) -
Boosting Hematopoietic Engraftment after in Utero Transplantation through Vascular Niche Manipulation
by: Saloomeh Mokhtari, et al.
Published: (2016-06-01) -
Correction: HCMV Protein LUNA Is Required for Viral Reactivation from Latently Infected Primary CD14+ Cells
by: Lisa R. Keyes, et al.
Published: (2013-01-01) -
HCMV protein LUNA is required for viral reactivation from latently infected primary CD14⁺ cells.
by: Lisa R Keyes, et al.
Published: (2012-01-01) -
Correction: HCMV Protein LUNA Is Required for Viral Reactivation from Latently Infected Primary CD14 Cells.
by: Lisa R. Keyes, et al.
Published: (2013-01-01)